dc.contributor.author | Malaysia, Kementerian Kesihatan | |
dc.date | 2022 | |
dc.date.accessioned | 2022-06-29T07:02:51Z | |
dc.date.available | 2022-06-29T07:02:51Z | |
dc.date.issued | 2022-05-12 | |
dc.identifier.citation | 2 p. | en_US |
dc.identifier.uri | http://dspace.unimap.edu.my:80/xmlui/handle/123456789/75716 | |
dc.description | This item is made available on Ministry of Health Malaysia, Covid-19 homepage at http://covid-19.moh.gov.my/ | en_US |
dc.language.iso | ms | en_US |
dc.publisher | Kementerian Kesihatan Malaysia (KKM) | en_US |
dc.subject.other | Covid 19 | en_US |
dc.subject.other | Covid 19 -- Malaysia | en_US |
dc.subject.other | Kenyataan Akhbar -- Kementerian Kesihatan Malaysia | en_US |
dc.subject.other | Status terkini | en_US |
dc.subject.other | Situasi semasa | en_US |
dc.subject.other | Coronavirus 2019 (Covid-19) | en_US |
dc.title | Kenyataan Media Kementerian Kesihatan Malaysia - Keputusan mesyuarat pihak berkuasa kawalan dadah kali ke-372 berkenaan pendaftaran produk bagi pencegahan Covid-19 | en_US |
dc.type | Article | en_US |
dc.identifier.url | http://covid-19.moh.gov.my/ | |